Immunomic Therapeutics
Sara Solt currently serves as a Senior Program Manager at Immunomic Therapeutics, Inc. since March 2024. Prior to this role, Sara was an Account Program Manager at Miltenyi Biotec from September 2021 to December 2023, where responsibilities included developing new client accounts and managing technical project timelines, contributing to annual sales exceeding $10M. At Thermo Fisher Scientific between June 2020 and September 2021, Sara held the position of Project Manager III, focused on maintaining client relationships and aligning project timelines with business needs. Sara's extensive experience began at Johns Hopkins School of Medicine, where, from May 2002 to June 2020, Sara managed laboratory operations, compliance, and staff while contributing to scientific literature and grants. Sara holds a Bachelor of Science in Cell Biology and Anatomy from Radford University and an Associate’s Degree in Veterinary/Animal Health Technology from Johnson College.
This person is not in any teams
This person is not in any offices
Immunomic Therapeutics
1 followers
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.